Asian Growth Companies Insiders Are Eager To Own

Amidst a backdrop of geopolitical tensions and fluctuating oil prices, Asian markets have shown resilience, with investors keeping a keen eye on growth opportunities in the region. In such an environment, companies with high insider ownership often stand out as they signal confidence from those closest to the business, making them intriguing prospects for growth-focused investors.

Top 10 Growth Companies With High Insider Ownership In Asia

Name	Insider Ownership	Earnings Growth
Suzhou Dongshan Precision Manufacturing (SZSE:002384)	33.5%	75.5%
Seojin SystemLtd (KOSDAQ:A178320)	18%	116.3%
Ningbo Sanxing Medical ElectricLtd (SHSE:601567)	24.9%	56.8%
L&C BIOLTD (KOSDAQ:A290650)	20.9%	163%
KCTech (KOSE:A281820)	20.6%	31.6%
Jiangxi Fushine Pharmaceutical (SZSE:300497)	21.1%	50.8%
JHT DesignLtd (SHSE:603061)	23.1%	48.6%
HUMAN MADE (TSE:456A)	23.9%	28.8%
Gpixel Changchun Microelectronics (SEHK:3277)	18.2%	31.9%
Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)	14.1%	39.2%

Click here to see the full list of 498 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

Newborn Town (SEHK:9911)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Newborn Town Inc. operates as a social networking entertainment company worldwide, with a market cap of HK$13.36 billion.

Operations: The company's revenue is primarily derived from its Social Networking Business, which accounts for $588.98 million, and its Innovative Business segment, contributing $71.67 million.

Insider Ownership: 31.1%

Newborn Town shows potential as a growth company with high insider ownership in Asia. Recent executive changes, including the appointment of Mr. Song Pengliang, highlight strategic leadership shifts. The company reported robust earnings for the first half of 2026, with sales reaching US$606.86 million and net income at US$99.33 million, indicating strong financial performance. Analysts forecast annual profit growth at 15.5%, outpacing the Hong Kong market's average, though revenue growth is slower than ideal benchmarks.

• Click here and access our complete growth analysis report to understand the dynamics of Newborn Town.
• According our valuation report, there's an indication that Newborn Town's share price might be on the cheaper side.

APT Medical (SHSE:688617)

Simply Wall St Growth Rating: ★★★★★☆

Overview: APT Medical Inc. focuses on the research, development, production, and sale of cardiovascular interventional medical devices in China with a market capitalization of CN¥34.14 billion.

Operations: The company's revenue is primarily derived from its medical products segment, totaling CN¥2.90 billion.

Insider Ownership: 20.3%

APT Medical demonstrates potential in Asia with significant insider ownership and strong financial performance. The company reported half-year sales of CNY 1.53 billion, up from CNY 1.21 billion a year ago, and net income increased to CNY 537.32 million. Analysts expect earnings growth of over 21% annually, below the market average but still substantial. Trading at a discount to its estimated fair value, APT Medical's revenue is projected to grow faster than the Chinese market rate.

• Delve into the full analysis future growth report here for a deeper understanding of APT Medical.
• Our valuation report unveils the possibility APT Medical's shares may be trading at a discount.

Pamica Technology (SZSE:001359)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Pamica Technology Corporation focuses on the R&D, production, and sale of mica insulation materials, glass fiber cloth, and new energy insulation materials globally, with a market cap of CN¥20.88 billion.

Operations: Pamica Technology Corporation generates revenue primarily from the Non-metallic Mineral Products Industry, amounting to CN¥1.30 billion.

Insider Ownership: 27.6%

Pamica Technology exhibits strong growth potential in Asia, driven by high insider ownership and robust revenue forecasts. The company reported half-year sales of CNY 680.58 million, an increase from the previous year, although net income slightly decreased to CNY 124.52 million. Despite recent share price volatility, earnings are projected to grow significantly at 44.55% annually, outpacing the Chinese market average. Revenue is also expected to expand faster than market rates at 29.6% per year.

• Click here to discover the nuances of Pamica Technology with our detailed analytical future growth report.
• In light of our recent valuation report, it seems possible that Pamica Technology is trading beyond its estimated value.

Next Steps

• Explore the 498 names from our Fast Growing Asian Companies With High Insider Ownership screener here.
• Searching for a Fresh Perspective? The end of cancer? These 35 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com